While our activities are diversified across our business segments and our markets, we have an overarching purpose – to make quality medicines accessible to the people who need them.
Develop and innovate
We are developing broad and differentiated portfolios of generic, branded generic and in-licensed products through internal R&D, co-development partnerships, licensing agreements and acquisitions.
Manufacture and maintain quality
We are committed to maintaining the highest quality standards in all our manufacturing facilities. We have 29 plants across the Group that supply our global markets with a broad range of injectable and non-injectable products, including 12 US FDA-approved facilities and 9 EU-approved facilities.
Markets across geographies
We actively promote, sell and distribute our products in our markets through experienced sales and manufacturing teams. In the MENA region, nearly 2,000 representatives market our brands to doctors and pharmacists, while our sales teams in the US and Europe are selling to a broad range of customers including wholesalers, pharmacy chains, governments and hospital purchasing organisations.
We provide our patients with access to high-quality, affordable medicines
By focusing on the empowerment and development of our people, we provide long and rewarding careers for our talented and diverse workforce.
Economic and financial returns are reinvested for future growth.
By conducting our business well and acting responsibly, we are benefiting the communities in which we operate.